According to a recently published report, The National Partnership to Improve Dementia Care in Nursing Homes provided an update that shows nursing homes have experienced a decline in antipsychotic use of between 18-21%. The Partnership has a mission to deliver health care that is person-centered, comprehensive and interdisciplinary with a specific focus on protecting residents from being prescribed antipsychotic medications unless there is a valid, clinical indication and a systematic process to evaluate each individual’s need.
The Centers for Medicare & Medicaid Services (CMS) is tracking the progress of the Partnership by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who are receiving an antipsychotic medication, excluding those residents diagnosed with schizophrenia, Huntington’s Disease, or Tourette’s Syndrome. In the fourth quarter of 2011 23.9% of long-stay nursing home residents were receiving an antipsychotic medication; since then there has been a decrease of 21.7% to a national prevalence of 18.7% in the first quarter of 2015. Success has varied by state and CMS region, with some states and regions having seen a reduction of greater than 20%.